- 2014
- Press releases - 28.11.2014
Action on malaria: 16 new mosquito genomes sequenced
The complete genomes of 16 anopheline mosquito species from the five continents have just been sequenced. Ten years of research have enabled an international consortium, coordinated by the University of Michigan and University of Notre Dame (United States) and including researchers from the French Institute for Development Research (IRD) and Inserm, to publish in the 27 November 2014 issue of the journal Science the DNA sequence for these mosquitoes, which are vectors of malaria.
- What's on? - 27.11.2014
Monday 1st December: World AIDS Day
The human immunodeficiency virus, named HIV, is a sexually transmitted disease that targets the immune system and weakens body’s systems that detect and defend against infection and certain types of cancer (source: World Health Organisation). AIDS is the abbreviated term for acquired immunodeficiency syndrome and is the most advanced stage of HIV infection. With more […]
- Press releases - 27.11.2014
Physical activity and prevention of falls in older people – A collective expert review by Inserm
Inserm was asked by the French Ministry of Community, Youth Affairs and Sports to prepare a collective expert report that would provide a review of the scientific knowledge regarding the contribution of physical activity to the prevention of falls in older people.
- Press releases - 26.11.2014
Anne Dejean-Assémat, is awarded the Inserm Grand Prix for 2014
The Inserm Grand Prix is awarded to Anne Dejean-Assémat, director of Inserm/Institut Pasteur Joint Unit 993 “Nuclear Organization and Oncogenesis,” for her entire body of research on the molecular and cellular mechanisms involved in the development of human cancers.
- Press releases - 24.11.2014
Stroke (CVA) in young adults: discovery of a susceptibility gene associated with bleeding of the cervical arteries
Researchers from the joint research unit “Public health and molecular epidemiology of aging related diseases” (Inserm/Institut Pasteur Lille/Université Lille 2), in collaboration with Lille Regional University Hospital (CHRU), have discovered a susceptibility gene involved in this major cause of stroke (cerebrovascular accident) in young subjects.
- Press releases - 20.11.2014
Pirate viruses caught in their own trap ?
A group of scientists in Strasbourg has demonstrated that one of the 80 components of each ribosome is essential for infection by certain viruses without being necessary for normal cell functioning.
- Press releases - 19.11.2014
Launch of GrippeNet.fr 2014-2015 season
Launched 3 years ago by the Sentinelles Network (Inserm–Pierre and Marie Curie University Joint Research Unit 1136) and the French Institute for Public Health Surveillance (InVS), the GrippeNet.fr website returns for a fourth consecutive year.
- Press releases - 17.11.2014
A better understanding of accidents in everyday life
During their lives, every French person will be the victim of one accident in everyday life every 5 years, on average (fall, burn, drowning, etc.). Taken as a whole, these statistics represent 11 million people injured every year. The Accident Prevention and Trauma Treatment team led by Emmanuel Lagarde (Inserm Unit 897), in partnership with Calyxis, is today launching the MAVIE study to find out the scale and nature of accidents in everyday life in France.
- Press releases - 14.11.2014
Avoiding skin graft rejection: it’s possible!
A research team bringing together José Cohen and Philippe Grimbert (Inserm Unit 955/Université Paris Est Créteil [UPEC] and the Centre for Clinical Investigation – Biotherapies 504 [CIC-BT 504]), and their collaborators at Institut Curie and AP-HP (George Pompidou European Hospital) has succeeded in finding a combination of drugs that reduces the risk of rejection following a skin graft. When tested in mice, this treatment seems effective, since no sign of rejection is observed nearly 30 days after transplantation.
- Press releases - 13.11.2014
MSF and Inserm join their forces against Ebola : first trials
In the absence of specific treatments for Ebola, international medical humanitarian organisation Médecins Sans Frontières/Doctors Without Borders (MSF) announced today that it will host clinical trials in three Ebola treatment centres in West Africa.